STOCKHOLM, April 30, 2019 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) has appointed Amy Pott as the new Head of Sobi North America. "Sobi North America is entering a new phase in line with Sobi's growth strategy, with the workforce growing more than fourfold in just more than a year. Amy Pott was most recently Group Vice President and US Franchise Head for Internal Medicine & Oncology at Shire. She was also Group Vice President for US Commercial Operations at Shire and Vice President of Strategy, Planning & Analytics at Baxalta, all roles based in Boston. Previous to her roles at Baxter and Shire, Pott held positions at the National Institute for Health & Clinical Excellence (NICE) and the NHS Confederation.

Source: The North Africa Journal April 30, 2019 11:15 UTC